SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

27 May 2026 Evaluate
The sales moved down -32.68% to Rs. 1835.17 millions for the March 2026 quarter as compared to Rs. 2725.96 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2026 is Rs. -56.50 millions as compared to Net Profit of Rs. 156.19 millions of corresponding quarter ended March 2025The Operating Profit of the company witnessed a decrease to 213.10 millions from 422.07 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1835.17 2725.96 -32.68 8379.18 8864.91 -5.48 8379.18 8864.91 -5.48
Other Income 153.02 89.37 71.22 349.51 206.15 69.54 349.51 206.15 69.54
PBIDT 213.10 422.07 -49.51 828.40 912.18 -9.18 828.40 912.18 -9.18
Interest 220.51 174.39 26.45 669.87 661.19 1.31 669.87 661.19 1.31
PBDT -33.52 250.32 -113.39 -4.17 -709.03 -99.41 -4.17 -709.03 -99.41
Depreciation 132.85 131.35 1.14 536.77 525.27 2.19 536.77 525.27 2.19
PBT -166.37 118.97 -239.84 -540.94 -1234.30 -56.17 -540.94 -1234.30 -56.17
TAX -109.87 -37.22 195.19 -211.26 -471.20 -55.17 -211.26 -471.20 -55.17
Deferred Tax -109.87 -37.22 195.19 -211.26 -487.80 -56.69 -211.26 -487.80 -56.69
PAT -56.50 156.19 -136.17 -329.68 -763.10 -56.80 -329.68 -763.10 -56.80
Equity 192.09 187.92 2.22 192.09 187.92 2.22 192.09 187.92 2.22
PBIDTM(%) 11.61 15.48 -25.00 9.89 10.29 -3.92 9.89 10.29 -3.92

Camlin Fine Sciences Share Price

137.35 -2.70 (-1.93%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2701.70
BASF India 3467.60
Tata Chemicals 732.60
Pidilite Inds. 1579.95
Deepak Nitrite 1658.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: